Cytokine-based therapies have been developed for cancer treatments, in particular human T cell growth factor, IL-2, has a main role in regulation of growth, differentiation and activation of tumor infiltrating lymphocytes (TLs) such as T cells and natural killers. This evidence concerns the gene IL2 and cancer.